Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
08/2000
08/09/2000EP1026160A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
08/09/2000EP1025106A2 Allosteric adenosine receptor modulators
08/09/2000EP1025105A1 Condensed benzothiopyranic compounds
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1024810A1 Method for optimizing retinal and optic nerve health
08/09/2000CN1262679A IL-5 inhibiting 6-azauracil derivatives
08/09/2000CN1262272A HIV proteinase inhibitor
08/08/2000US6100404 Erythromycin compounds
08/08/2000US6100265 Benzothiopyran and thienothiopyran derivatives; serotonin-2 blocking action; treatment of circulatory diseases in general such as hypertension, ischemic heart disease, cerebrovascular disturbance, and peripheral circulatory disturbance
08/08/2000US6100252 Specified compounds including methyl 2-butyl-1-((2'-(2-oxo-3h-1,2,3,5-oxathiadiazol-4-yl)biphenyl) methyl)-benzimidazole-7-carboxylate; use to treat circulatory diseases such as hypertensive diseases and heart diseases
08/08/2000US6100246 Spiro-piperidine derivatives as inhibitors of nitric oxide synthase
08/03/2000WO2000044755A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
08/03/2000WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents
08/03/2000WO2000031082A8 Pyrimidin-4-enamine as fungicide
08/03/2000WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
08/02/2000EP1023296A1 3-substituted pyrido 3',4':4,5] thieno 2,3-d] pyrimidine derivatives, and production and use of the same
08/02/2000EP0885229B1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
08/02/2000EP0527889B1 Quinolizinone type compounds
08/01/2000CA2178760C Hiv protease inhibitors
07/2000
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses
07/26/2000EP1021451A1 Asymmetric synthesis and catalysis with chiral heterocyclic compounds
07/26/2000EP1021449A1 Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates
07/26/2000EP1021448A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS
07/26/2000EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/26/2000CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
07/26/2000CN1261073A Tricyclooxime ethers, preparations thereof and medicinal compositions containing them
07/26/2000CN1054851C 3-aryl-pyrone derivatives and their preparing methods and uses as pesticides and herbicides
07/25/2000US6093727 A selective agonists for human alpha 2 receptors for treating disorders as hypertension, pain, glaucoma, alcohol and drug withdrawal, ischemia, rheumatoid arthritis, migraine, cognitive deficiency, spasticity, diarrhea, nasal congestion
07/25/2000US6093723 An immunomodulator for treating and preventing immune disorders, including autoimmune disease, inflammatory disease, organ transplant rejection and other disorders associated with il-2 mediated immune response
07/25/2000CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
07/20/2000WO2000042026A1 Non-peptide glp-1 agonists
07/20/2000WO2000041696A1 Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances
07/20/2000WO2000041695A1 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
07/20/2000WO2000001687A9 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
07/20/2000WO1999064048A9 Inhibitors of hiv reverse transcriptase
07/20/2000CA2359253A1 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
07/19/2000EP1020467A1 N-acylamino acid amide compounds and intermediates for preparation thereof
07/19/2000EP1020445A1 Fused pyridine derivatives
07/19/2000EP1019534A1 Multifunctional linking reagents for synthesis of branched oligomers
07/19/2000EP1019411A1 Process for synthesizing carbapenem side chain intermediates
07/19/2000EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
07/19/2000EP1019385A1 Aminoaryl oxazolidinone n-oxides
07/19/2000EP1019370A1 Ace-inhibitor nitric salts
07/19/2000EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1018880A1 2-methyl-thieno-benzodiazepine formulation
07/19/2000CN1260797A 3-substituted 3,4-dihydro-thieno (2,3-d) pyrimidine derivatives and preparation and use of same
07/19/2000CN1260780A Ace-inhibitor nitric salts
07/18/2000US6090797 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
07/13/2000WO2000024741A3 Dihydropyridine compounds and their use as potassium channel openers
07/13/2000WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors
07/13/2000DE19900673A1 Verwendung von Bindungspartnern für 5-HT5-Rezeptoren zur Behandlung neurodegenerativer und neuropsychiatrischer Störungen Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders
07/13/2000DE19900545A1 Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia
07/12/2000EP1018514A1 NF-$g(k)B INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT
07/12/2000EP1017735A1 Compounds for electronic devices
07/12/2000EP1017697A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
07/12/2000CN1259954A 3-substituted pyrido [3',4' : 4,5] thieno [2,3D} pyrimidine derivatives, prodn. and use thereof
07/12/2000CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them
07/12/2000CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them
07/11/2000US6087380 Antithrombotic benzimidazoles; anticoagulants; 2-(n-(4-amidinophenyl)-aminomethyl)-benzimidazol-5-yl-carboxylic acids
07/11/2000US6087357 Piperazine derivatives as tachykinin antagonists
07/11/2000CA2208569C Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
07/06/2000WO2000039108A1 Thrombin or factor xa inhibitors
07/06/2000WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS
07/06/2000WO2000038687A1 Protease inhibitors
07/06/2000WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000CA2356671A1 Protease inhibitors
07/06/2000CA2349557A1 Thrombin or factor xa inhibitors
07/06/2000CA2348740A1 Thrombin or factor xa inhibitors
07/06/2000CA2320730A1 Thrombin or factor xa inhibitors
07/05/2000EP1016664A1 Fused thiophene compounds and medicinal use thereof
07/05/2000EP1015435A1 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
07/05/2000EP1015434A2 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
07/05/2000EP0697021B1 Photo-activatable biotin derivatives and their use in suppressing interference in immuno assaying
07/05/2000EP0675889B1 Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives
07/05/2000CN1259132A Compounds
07/05/2000CN1259131A Compounds
07/04/2000US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer
07/04/2000US6083952 Compounds
07/04/2000CA1341044C Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use
06/2000
06/29/2000WO2000037470A1 Antihistaminic spiro compounds
06/29/2000WO2000037466A1 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS
06/29/2000WO2000037462A1 Non-peptide nk1 receptors antagonists
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000DE19962661A1 Hexahydro-2-oxo-1H-thieno (3,4-d) imidazole-4-pentanoic acid preparation from benzylated analog using inexpensive sulfuric acid, used e.g. as food or feed additive
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/28/2000EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity
06/28/2000EP1011726A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
06/28/2000EP1011665A1 Heterocyclic agents
06/28/2000EP0808318B1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists
06/28/2000CN1258297A Process for producing beta-lactam derivs.
06/27/2000US6080745 For treating or preventing disorders of dopamine system, such as schizophrenia
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000CA2355202A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors